
The Department of Medical Services (DMS) on Monday defended the effectiveness of favipiravir in treating Covid-19 patients against an international study claiming the antiviral drug lacked efficacy in treatments.
Dr Somsak Akksilp, DMS director-general, said the study he is referring to is one carried out in the United States, Mexico and Brazil.